Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $157,222 | $153,854 | $153,988 | $159,557 |
| - Cash | $45,116 | $43,411 | $54,093 | $63,059 |
| + Debt | $3,850 | $3,850 | $3,850 | $3,850 |
| Enterprise Value | $115,956 | $114,293 | $103,745 | $100,348 |
| Revenue | $139 | $18,867 | $18,045 | $24,618 |
| % Growth | -99.3% | 4.6% | -26.7% | – |
| Gross Profit | $79 | $9,872 | $9,340 | $15,090 |
| % Margin | 57.1% | 52.3% | 51.8% | 61.3% |
| EBITDA | $12 | $0 | -$3,750 | $6,532 |
| % Margin | 8.9% | 0% | -20.8% | 26.5% |
| Net Income | $5 | $271 | -$5,230 | $4,889 |
| % Margin | 3.5% | 1.4% | -29% | 19.9% |
| EPS Diluted | 0.13 | 7.12 | -133.99 | 129.09 |
| % Growth | -98.2% | 105.3% | -203.8% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |